Safi U Khan1, Siva H Yedlapati2, Ahmad N Lone1, Muhammad Shahzeb Khan3, Nanette K Wenger4, Karol E Watson5, Martha Gulati6, Allison G Hays7, Erin D Michos7,8. 1. Department of Medicine, West Virginia University, Morgantown, WV, USA. 2. Department of Medicine, Erie County Medical Center, Buffalo, NY, USA. 3. Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA. 4. Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA. 5. Department of Medicine, Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. 6. Department of Medicine, Division of Cardiology, University of Arizona, Phoenix, AZ, USA. 7. Department of Medicine, Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, MD, USA. 8. Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Blalock 524-B, 600 N. Wolfe Street, Baltimore, MD 21287, USA.
Abstract
AIMS: To compare premature heart disease- and cancer-related deaths in women in the USA. METHODS AND RESULTS: We analysed the US national database of death certificates of women aged <65 from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research database between 1999 and 2018. We measured annual percentage changes (APCs) in age-adjusted mortality rates (AAMRs) and years of potential life lost per 100 000 persons due to heart disease and cancer. Overall, cancer was a more prevalent cause of premature death compared with heart disease. Between 1999 and 2018, the AAMRs decreased for both cancer (61.9/100 000 to 45.6/100 000) and heart disease (29.2/100 000 to 22.6/100 000). However, while APC in AAMR for cancer declined consistently over time, after an initial decline, APC in AAMR for heart disease increased between 2010 and 2018 [0.53 95% confidence interval (0.18-0.89)], with a significant rise in Midwest, medium/small metros, and rural areas after 2008. Compared with cancer, APC in AAMR for heart disease increased in women aged 25-34 years [2.24 (0.30-4.22); 2013-18) and 55-64 years [0.46 (0.13-0.80); 2009-13], as well as Non-Hispanic (NH) Whites [APC, 0.79 (0.46-1.13); 2009-18] and NH American Indian/Alaskan Native [2.71 (0.59-4.87); 2011-2018]. Consequently, the mortality gap between cancer and heart disease has narrowed from an AAMR of 32.7/100 000 to 23.0/100 000. CONCLUSIONS: The mortality gap between cancer and heart disease is decreasing among women <65 years. Intensive cardiovascular health interventions are required focusing on vulnerable young demographic subgroups and underserved regional areas to meet the American Heart Association's Impact Goal and Million Hearts Initiative. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: To compare premature heart disease- and cancer-related deaths in women in the USA. METHODS AND RESULTS: We analysed the US national database of death certificates of women aged <65 from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research database between 1999 and 2018. We measured annual percentage changes (APCs) in age-adjusted mortality rates (AAMRs) and years of potential life lost per 100 000 persons due to heart disease and cancer. Overall, cancer was a more prevalent cause of premature death compared with heart disease. Between 1999 and 2018, the AAMRs decreased for both cancer (61.9/100 000 to 45.6/100 000) and heart disease (29.2/100 000 to 22.6/100 000). However, while APC in AAMR for cancer declined consistently over time, after an initial decline, APC in AAMR for heart disease increased between 2010 and 2018 [0.53 95% confidence interval (0.18-0.89)], with a significant rise in Midwest, medium/small metros, and rural areas after 2008. Compared with cancer, APC in AAMR for heart disease increased in women aged 25-34 years [2.24 (0.30-4.22); 2013-18) and 55-64 years [0.46 (0.13-0.80); 2009-13], as well as Non-Hispanic (NH) Whites [APC, 0.79 (0.46-1.13); 2009-18] and NH American Indian/Alaskan Native [2.71 (0.59-4.87); 2011-2018]. Consequently, the mortality gap between cancer and heart disease has narrowed from an AAMR of 32.7/100 000 to 23.0/100 000. CONCLUSIONS: The mortality gap between cancer and heart disease is decreasing among women <65 years. Intensive cardiovascular health interventions are required focusing on vulnerable young demographic subgroups and underserved regional areas to meet the American Heart Association's Impact Goal and Million Hearts Initiative. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Erin D Michos; Tina K Reddy; Martha Gulati; LaPrincess C Brewer; Rachel M Bond; Gladys P Velarde; Alison L Bailey; Melvin R Echols; Samar A Nasser; Harold E Bays; Ann Marie Navar; Keith C Ferdinand Journal: Am J Prev Cardiol Date: 2021-08-20
Authors: Emily Aldridge; Maleesa Pathirana; Melanie Wittwer; Susan Sierp; Shalem Y Leemaqz; Claire T Roberts; Gustaaf A Dekker; Margaret A Arstall Journal: Front Cardiovasc Med Date: 2022-03-14
Authors: Nathan D Wong; Matthew J Budoff; Keith Ferdinand; Ian M Graham; Erin D Michos; Tina Reddy; Michael D Shapiro; Peter P Toth Journal: Am J Prev Cardiol Date: 2022-03-15
Authors: Ellise T Gambahaya; Anum S Minhas; Garima Sharma; Arthur J Vaught; Luigi Adamo; Sammy Zakaria; Erin D Michos; Allison G Hays Journal: CJC Open Date: 2021-12-16
Authors: Angelica Ezeigwe; Oluseye Ogunmoroti; Anum S Minhas; Carla P Rodriguez; Brigitte Kazzi; Oluwaseun E Fashanu; Olatokunbo Osibogun; Lara C Kovell; Colleen M Harrington; Erin D Michos Journal: Front Cardiovasc Med Date: 2022-09-14
Authors: Sarju Ganatra; Sourbha S Dani; Ashish Kumar; Safi U Khan; Rishi Wadhera; Tomas G Neilan; Paaladinesh Thavendiranathan; Ana Barac; Joerg Hermann; Monika Leja; Anita Deswal; Michael Fradley; Jennifer E Liu; Diego Sadler; Aarti Asnani; Lauren A Baldassarre; Dipti Gupta; Eric Yang; Avirup Guha; Sherry-Ann Brown; Jennifer Stevens; Salim S Hayek; Charles Porter; Ankur Kalra; Suzanne J Baron; Bonnie Ky; Salim S Virani; Dhruv Kazi; Khurram Nasir; Anju Nohria Journal: JACC CardioOncol Date: 2022-09-20